<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Institute of Child Health</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/16F80C41-AB8F-4475-90D3-2C1A3B47E9BD"><gtr:id>16F80C41-AB8F-4475-90D3-2C1A3B47E9BD</gtr:id><gtr:firstName>Aoife</gtr:firstName><gtr:surname>Waters</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802138"><gtr:id>6DE66D12-C2C7-431D-979A-1D00BA75A52D</gtr:id><gtr:title>The Role of Notch-RFX Signaling in Ciliogenesis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0802138</gtr:grantReference><gtr:abstractText>Every organ in the body has unique functions which facilitates the body?s ability to react to environmental stimuli. An organ is made up of cells with different characteristics which allow that organ to carry out its function. While all cells are initially derived from a single cell type, a programme of genes within a given cell can tell that cell what to become. Chemicals secreted by signal-sending cells can activate a programme of genes in neighbouring cells which receive the signal. As a result, proteins are made within the cell which interact with each other and carry out the special functions of that cell. Sensing changes in the environment is a unique cellular function that is undertaken by structures called cilia which project from the cell surface. Many diseases can result from processes which interfere with the synthesis and function of cilia. We, in the Beales laboratory aim to identify the chemical signals which instruct cells to make cilia. At the same time, we will be investigating genetic defects in a family with a rare cilia-related disease. This work has important implications for the treatment of a wide range of cilia-related diseases that include kidney failure, obesity and diabetes.</gtr:abstractText><gtr:technicalSummary>The Role of Notch-RFX Signaling in Ciliogenesis

Background: Ciliopathies encompass a wide range of developmental diseases that include cystic kidney disease, left-right asymmetry, maturity onset obesity and pleiotropic syndromes including Bardet Biedl syndrome (BBS). While genetic mutations encoding components of the primary cilium have been identified in many ciliopathies, little is known about the upstream molecular pathways regulating ciliogenesis or the differentiation of ciliated cells. A conserved ciliogenic role for the family of regulatory transcription factor X (RFX) has been demonstrated in the nematode, fruitfly, zebrafish and mouse. Subsets of ciliogenic genes are regulated by Rfx and encode proteins such as the BBS proteins and those involved in intraflagellar transport (IFT). Recent work proposes that Notch signaling regulates rfx2 expression during ciliated cell fate specification in the developing zebrafish pronephros while genetic and pharmacological inhibition of Notch signalling can rescue the cystic kidney phenotype of certain ciliopathy mutants by upregulating rfx2 expression.
Objectives: To determine whether a conserved role exists for Notch-RFX signaling in specification of mammalian ciliated cell fate during organogenesis and whether certain human ciliopathies may result from defective Notch/RFX signaling.
Design: A spatiotemporal expression analysis of Rfx2 and Rfx3 protein and mRNA will be undertaken during murine nephronogenesis at E13.5 (when nephronogenesis and branching morphogenesis are established), E15.5 and E18.5 (when renal filtration is evident) and postnatal (P) day 21 (when nephronogenesis is complete). A subsequent spatiotemporal expression analysis of Notch ligands, receptors and molecular targets in relation to Rfx expression will be employed at similar developmental time-points. In order to determine the temporal requirement for Notch signalling in determining Rfx expression, I will utilize a novel inducible transgenic mouse model of 
RBPJ-kappa deletion (inhibition of canonical Notch signaling) to examine Rfx expression at the same aforementioned time-points of murine nephrogenesis. Genetic sequencing for RFX mutations in a family with a unique syndrome with clinical features similar to Rfx3 null mice will also be undertaken.
Methodology: Techniques such as immunohistochemistry, immunofluorescence microscopy, in situ hybridization, inducible transgenic mouse systems, polymerase chain reaction, generation of zebrafish morphants, zebrafish therapeutics, positional cloning and gene sequencing will be employed. Advanced sequencing techniques such as customized exon arrays of the region (Nimblegen) followed by 454/Solexa sequencing may also be employed. 
Scientific opportunities: Determination of a novel conserved pathway during organogenesis and disease. Advancement of knowledge pertaining to the molecular regulation of ciliogenesis 
Medical opportunities: Potential therapeutic modulation of molecular pathways for a range of human ciliopathies.</gtr:technicalSummary><gtr:fund><gtr:end>2012-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>391667</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Biosciences</gtr:department><gtr:description>Whole Exome Sequencing Identifies Genetic Cause of New Ciliopathy Syndrome</gtr:description><gtr:id>34308AB3-86AC-4863-8033-B3DD003F8E58</gtr:id><gtr:impact>Establishment of UCL Whole Exome Sequencing pipeline for UCL
Multidisciplinary: UCL bioinformatics team, GOSgene team</gtr:impact><gtr:outcomeId>oCKfjk3usJ2-1</gtr:outcomeId><gtr:partnerContribution>Bioinformatic analysis</gtr:partnerContribution><gtr:piContribution>Identification of genetic cause of a novel phenotype</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Biosciences</gtr:department><gtr:description>A Novel Role for rfx3 in Zebrafish Notochord Morphogenesis</gtr:description><gtr:id>A9BFD273-3BF2-4DA9-B5BC-BA01CD86FC5A</gtr:id><gtr:impact>A manuscript is currently in revision for Developmental Biology</gtr:impact><gtr:outcomeId>j4bqUWo6btf-1</gtr:outcomeId><gtr:partnerContribution>We have submitted a paper to Developmental Biology which is now in revision</gtr:partnerContribution><gtr:piContribution>We have made a novel observation for a role for rfx3 in zebrafish notochord development</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Ciliopathy Alliance UK</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C0F87AB9-40F9-4F3D-A331-EFB508C4DE13</gtr:id><gtr:impact>Expert panel consisting of clinicians, scientists, patient support groups influencing national commissioning for a centre for ciliopathy disease.

National Centre for Ciliopathic Diseases commissioned.</gtr:impact><gtr:outcomeId>o7kVmi9E2dZ</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2011,2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>The United Kingdom Centre for Ciliopathies (UKCC)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6A95F559-C4DE-4B93-935F-2D1903B9ED53</gtr:id><gtr:outcomeId>aHCvS8XhFPn</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>5781A891-1CB0-4F72-A18F-8878A6F5CDE3</gtr:id><gtr:title>Severe atypical HUS caused by CFH S1191L--case presentation and review of treatment options.</gtr:title><gtr:parentPublicationTitle>Pediatric nephrology (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5bd26aa504afe8ca8fd38971227081d9"><gtr:id>5bd26aa504afe8ca8fd38971227081d9</gtr:id><gtr:otherNames>De S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0931-041X</gtr:issn><gtr:outcomeId>C0D12174434</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76E6EC98-88D6-4B24-B617-43C78DC46170</gtr:id><gtr:title>Ciliopathies: an expanding disease spectrum.</gtr:title><gtr:parentPublicationTitle>Pediatric nephrology (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/496c6f8776d1651525ea524984415a40"><gtr:id>496c6f8776d1651525ea524984415a40</gtr:id><gtr:otherNames>Waters AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0931-041X</gtr:issn><gtr:outcomeId>nUAxoxt4U8P</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>745AE60E-7D7C-47AF-B761-2DF67345BE7A</gtr:id><gtr:title>A founder mutation in Vps37A causes autosomal recessive complex hereditary spastic paraparesis.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d984b3c94df0b78b90e05453067f6aa"><gtr:id>3d984b3c94df0b78b90e05453067f6aa</gtr:id><gtr:otherNames>Zivony-Elboum Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>pm_13447_27_22717650</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E18FB7F4-C728-4A91-B43C-F22838CF40B8</gtr:id><gtr:title>Ectopic notch activation in developing podocytes causes glomerulosclerosis.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/496c6f8776d1651525ea524984415a40"><gtr:id>496c6f8776d1651525ea524984415a40</gtr:id><gtr:otherNames>Waters AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn><gtr:outcomeId>6E1E251E466</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59E318A6-6AE5-4164-935D-2A65F64382FB</gtr:id><gtr:title>Integrin a3 mutations with kidney, lung, and skin disease.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b02fe832d866703ab0e90f5118d33c2"><gtr:id>7b02fe832d866703ab0e90f5118d33c2</gtr:id><gtr:otherNames>Has C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>pm_13447_27_22512483</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE3A384E-FF71-4BEE-9EC7-CEC66C7EC88C</gtr:id><gtr:title>Atypical p-ANCA is not a poor prognostic marker in Postinfectious Glomerulonephritis.</gtr:title><gtr:parentPublicationTitle>Pediatric nephrology (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7844b6d1dfff2f36bfcbc29f47fd35b0"><gtr:id>7844b6d1dfff2f36bfcbc29f47fd35b0</gtr:id><gtr:otherNames>Waters A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0931-041X</gtr:issn><gtr:outcomeId>FCAD3B9652C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68ABD2C7-E978-45D3-B838-41BC1537275A</gtr:id><gtr:title>Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T.</gtr:title><gtr:parentPublicationTitle>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/496c6f8776d1651525ea524984415a40"><gtr:id>496c6f8776d1651525ea524984415a40</gtr:id><gtr:otherNames>Waters AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1600-6135</gtr:issn><gtr:outcomeId>5AB8E7009AB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB1D0D31-229B-4EDE-A1C5-F6FFBE6C7205</gtr:id><gtr:title>Optimizing treatment strategies in paediatric atypical hemolytic uremic syndrome.</gtr:title><gtr:parentPublicationTitle>Pediatric nephrology (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7844b6d1dfff2f36bfcbc29f47fd35b0"><gtr:id>7844b6d1dfff2f36bfcbc29f47fd35b0</gtr:id><gtr:otherNames>Waters A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0931-041X</gtr:issn><gtr:outcomeId>AAW6mKM6x3e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61E68FDB-E999-46EB-95CC-81965E310015</gtr:id><gtr:title>aHUS caused by complement dysregulation: new therapies on the horizon.</gtr:title><gtr:parentPublicationTitle>Pediatric nephrology (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/496c6f8776d1651525ea524984415a40"><gtr:id>496c6f8776d1651525ea524984415a40</gtr:id><gtr:otherNames>Waters AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0931-041X</gtr:issn><gtr:outcomeId>sjeevjE4JSR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04F5D3A9-229E-4FFB-BA8E-4EFBE9378235</gtr:id><gtr:title>Characterisation and validation of insertions and deletions in 173 patient exomes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e624c5192e4cb8e4e04042cdb89976af"><gtr:id>e624c5192e4cb8e4e04042cdb89976af</gtr:id><gtr:otherNames>Lescai F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13447_27_23251486</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A4959A3-D4F2-4EE8-907F-9648BB7764D3</gtr:id><gtr:title>Successful treatment of DEAP-HUS with eculizumab.</gtr:title><gtr:parentPublicationTitle>Pediatric nephrology (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bd5e48dba40e68b85295447c1360427"><gtr:id>1bd5e48dba40e68b85295447c1360427</gtr:id><gtr:otherNames>Noone D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0931-041X</gtr:issn><gtr:outcomeId>5454ae8f406829.52233462</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>854130EA-AF66-4E5D-8BBC-CCCD23C54D99</gtr:id><gtr:title>The kinetochore protein, CENPF, is mutated in human ciliopathy and microcephaly phenotypes.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/496c6f8776d1651525ea524984415a40"><gtr:id>496c6f8776d1651525ea524984415a40</gtr:id><gtr:otherNames>Waters AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>56e08812247531.02118265</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A643822C-D5A6-4E4D-9407-8D4E04925C02</gtr:id><gtr:title>Notch promotes dynamin-dependent endocytosis of nephrin.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/496c6f8776d1651525ea524984415a40"><gtr:id>496c6f8776d1651525ea524984415a40</gtr:id><gtr:otherNames>Waters AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn><gtr:outcomeId>GX48wK2q6My</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B900663C-6380-4904-B7B2-31401C0D6515</gtr:id><gtr:title>Growth in PHEX-associated X-linked hypophosphatemic rickets: the importance of early treatment.</gtr:title><gtr:parentPublicationTitle>Pediatric nephrology (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82c5a8e19395c152ce206ea808af5f67"><gtr:id>82c5a8e19395c152ce206ea808af5f67</gtr:id><gtr:otherNames>Quinlan C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0931-041X</gtr:issn><gtr:outcomeId>pm_13447_27_22101457</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>417B3CCC-B787-4304-B9C4-59E6D290A8CB</gtr:id><gtr:title>An enzyme-linked immunosorbent assay (ELISA) for quantification of human collectin 11 (CL-11, CL-K1).</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28e1406579e2cec2b3735eef0b9d6652"><gtr:id>28e1406579e2cec2b3735eef0b9d6652</gtr:id><gtr:otherNames>Selman L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn><gtr:outcomeId>pm_13447_27_22301270</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E625B627-C341-4C2E-965F-95A255E37C21</gtr:id><gtr:title>Clinico-pathological correlations of congenital and infantile nephrotic syndrome over twenty years.</gtr:title><gtr:parentPublicationTitle>Pediatric nephrology (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e6b8c59178e77a2745a4ff4a60f4205"><gtr:id>0e6b8c59178e77a2745a4ff4a60f4205</gtr:id><gtr:otherNames>Kari JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0931-041X</gtr:issn><gtr:outcomeId>5454ae8f6af1c4.98484429</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8830E87E-BD25-4679-BB75-798F0DB7E1EC</gtr:id><gtr:title>Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United kingdom experience.</gtr:title><gtr:parentPublicationTitle>The Journal of pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/496c6f8776d1651525ea524984415a40"><gtr:id>496c6f8776d1651525ea524984415a40</gtr:id><gtr:otherNames>Waters AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3476</gtr:issn><gtr:outcomeId>B89EDB1AE7A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC1192E6-B6AE-4173-9371-82B4168E7521</gtr:id><gtr:title>Is complement a culprit in infection-induced forms of haemolytic uraemic syndrome?</gtr:title><gtr:parentPublicationTitle>Immunobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/353e752deb089a0d0e572cf98e705365"><gtr:id>353e752deb089a0d0e572cf98e705365</gtr:id><gtr:otherNames>Johnson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0171-2985</gtr:issn><gtr:outcomeId>JTbLLKjALJD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F0ECAD8-B51C-4E33-9033-8BA7C22A4B53</gtr:id><gtr:title>Whole exome sequencing identifies the genetic cause of a new ciliopathy syndrome</gtr:title><gtr:parentPublicationTitle>PEDIATR NEPHROL</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c518143ad8aa225fd64811286cf5abc2"><gtr:id>c518143ad8aa225fd64811286cf5abc2</gtr:id><gtr:otherNames>Waters, Aoife</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>hsqjxhJS5Pq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEE97E9E-F91B-4804-83D1-E1F5DD42DF34</gtr:id><gtr:title>The clinical spectrum of hemolytic uremic syndrome secondary to complement factor H autoantibodies.</gtr:title><gtr:parentPublicationTitle>Clinical nephrology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d75c0bcc9053e9a07e2905e563de2ba8"><gtr:id>d75c0bcc9053e9a07e2905e563de2ba8</gtr:id><gtr:otherNames>Kim JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0301-0430</gtr:issn><gtr:outcomeId>5454ae8f147665.13026925</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0065E34A-B8EA-4DD5-8C2C-C96A6BF1B497</gtr:id><gtr:title>Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c83e39d795bac0656b65c0f2a6d339c"><gtr:id>1c83e39d795bac0656b65c0f2a6d339c</gtr:id><gtr:otherNames>Rooryck C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>oHK82VggZM4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B451390-3C1D-49C0-8194-A098828ADD9A</gtr:id><gtr:title>Paediatrics: Long-term effects of Wilms tumour therapy on renal function.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Urology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/496c6f8776d1651525ea524984415a40"><gtr:id>496c6f8776d1651525ea524984415a40</gtr:id><gtr:otherNames>Waters AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1759-4812</gtr:issn><gtr:outcomeId>56e088c97b1473.04002773</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4F81190-78AF-448C-9B28-543441B5102D</gtr:id><gtr:title>Tubulointerstitial nephritis as an extraintestinal manifestation of Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Nature clinical practice. Nephrology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/496c6f8776d1651525ea524984415a40"><gtr:id>496c6f8776d1651525ea524984415a40</gtr:id><gtr:otherNames>Waters AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1745-8323</gtr:issn><gtr:outcomeId>CCD7FED81F7</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802138</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>2EEE0958-6BE1-4D16-B86B-5D954CD37219</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Renal and Urogenital</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>